Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.7M
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
1.03M
-
Shares change
-
-81.7K
-
Total reported value, excl. options
-
$2.46M
-
Value change
-
-$456K
-
Put/Call ratio
-
0.54
-
Number of buys
-
9
-
Number of sells
-
-7
-
Price
-
$2.37
Significant Holders of Altimmune, Inc. - Common Stock (ALT) as of Q2 2019
23 filings reported holding ALT - Altimmune, Inc. - Common Stock as of Q2 2019.
Altimmune, Inc. - Common Stock (ALT) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.03M shares
of 80.7M outstanding shares and own 1.28% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (480K shares), MORGAN STANLEY (130K shares), GEODE CAPITAL MANAGEMENT, LLC (84.8K shares), DIMENSIONAL FUND ADVISORS LP (74.6K shares), BANK OF AMERICA CORP /DE/ (50K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (48.7K shares), BlackRock Inc. (36.4K shares), SABBY MANAGEMENT, LLC (34.2K shares), Bank of New York Mellon Corp (33.2K shares), and CITADEL ADVISORS LLC (24.8K shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.